China’s National Medical Products Administration granted conditional approval to the drug Oligomannate (GV-971), the regulator said in a statement on its website. Shanghai Green Valley Pharmaceuticals ...
-
-
Recent Updates
- China Tightens Export Rules for Drug Precursors Prior to Summit
- China’s New Export Regulations Impact Drug Precursors Trade
- CATL Expands Battery Cell Production to Europe
- Huawei’s New Kirin 9050 Pro Reduces Gap with Apple Chips in Breakthrough
- EU Faces Widening Trade Deficit with China Amid Import Disparity
- High Stakes Meeting: AI, Trade, and Global Power Play Between Trump and Xi
- Alibaba Shocks World with Newest Chinese AI Chip Revelation
- Shanghai: China’s greatest city is sinking, unequal, and running out of time
- Qingpu Bailian Outlets Expands, Reinventing Shopping Experience in Western Shanghai
- China-to-US East Coast Freight Tops $10,000 for First Time Since 2022
Blogroll